Who
Glynn Wilson
Chief Executive Officer
Company insider
Files Form 4 as: Director, Cadrenal Therapeutics; Chief Executive Officer, Caring Brands; Former CSO, Chairman, Bonk; Chief Executive Officer, Marker Therapeutics.
In numbers
- Trades disclosed
- 40
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $140K
- Companies
- 4
- Companies where not an officer
- 1
- First trade
- 29 Jun 2009
- Last trade
- 9 Oct 2026
- Last filed
- 16 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Oct 2026filed 13 Oct 2026 | CVKD Cadrenal Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 6 Oct 2026filed 16 Oct 2026 | CABR Caring Brandsoption or derivative · Household & Personal Care | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 27 Mar 2026filed 27 Mar 2026 | CABR Caring BrandsHousehold & Personal Care | SEC FORM 4 Code D | $750K1,500,000 at $0.50 | filing |
| 27 Mar 2026filed 27 Mar 2026 | CABR Caring BrandsHousehold & Personal Care | SEC FORM 4 Code D | $750K1,500,000 at $0.50 | filing |
| 11 Dec 2025filed 15 Dec 2025 | CABR Caring BrandsHousehold & Personal Care | SEC FORM 4 Code A | —126,720 at $0.00 | filing |
| 11 Dec 2025filed 15 Dec 2025 | CABR Caring BrandsHousehold & Personal Care | SEC FORM 4 Code A | —45,872 at $0.00 | filing |
| 23 Jan 2025filed 24 Jan 2025 | CVKD Cadrenal Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 1 Mar 2024filed 6 Mar 2024 | BNKK Bonkoption or derivative · Household & Personal Care | SEC FORM 4 Code D | —1,900,000 | filing |
| 18 Jan 2024filed 19 Jan 2024 | CVKD Cadrenal Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 24 Jan 2023filed 24 Jan 2023 | CVKD Cadrenal Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —50,000 | filing |
| 24 Jan 2023filed 24 Jan 2023 | CVKD Cadrenal TherapeuticsBiotechnology | SEC FORM 4 Code C | —50,000 | filing |
| 30 Dec 2022filed 30 Dec 2022 | BNKK Bonkoption or derivative · Household & Personal Care | SEC FORM 4 Code A | —1,050,000 | filing |
| 26 Jul 2022filed 30 Dec 2022 | BNKK BonkHousehold & Personal Care | SEC FORM 4 Code D | —14,124 | filing |
| 26 Jul 2022filed 27 Jul 2022 | BNKK Bonkoption or derivative · Household & Personal Care | SEC FORM 4 Code D | —2,750 | filing |
| 26 Jul 2022filed 27 Jul 2022 | BNKK BonkHousehold & Personal Care | SEC FORM 4 Code D | —14,124 | filing |
| 6 Dec 2021filed 27 Jan 2022 | BNKK Bonkoption or derivative · Household & Personal Care | SEC FORM 4 Code A | —25,000 | filing |
| 24 Nov 2021filed 29 Nov 2021 | BNKK Bonkoption or derivative · Household & Personal Care | SEC FORM 4 Code A | —875,000 | filing |
| 10 Nov 2021filed 15 Nov 2021 | BNKK BonkHousehold & Personal Care | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 16 Aug 2021filed 18 Aug 2021 | BNKK Bonkoption or derivative · Household & Personal Care | SEC FORM 4 Code A | —155,444 at $0.00 | filing |
| 16 Aug 2021filed 18 Aug 2021 | BNKK BonkHousehold & Personal Care | SEC FORM 4 Code A | —14,124 at $0.00 | filing |
News
Bonk (NASDAQ:BNKK) & Loomis (OTCMKTS:LOIMF) Critical SurveyBNKK · dailypolitical.com · 6 Oct 2026
0 headlines in the last 90 days name Glynn Wilson; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.